The evolution of hemoglobin A1c targets for youth with type 1 diabetes: rationale and supporting evidence
Redondo MJ, Libman I, Maahs DM, et al.
Diabetes Care. 2021;44(2):301-312
Leggi
Effects of sotagliflozin combined with intensive insulin therapy in young adults with poorly controlled type 1 diabetes: The JDRF Sotagliflozin Study
Bode BW, Cengiz E, Wadwa RP, et al.
Diabetes Technol Ther. 2021;23(1):59-69.
Leggi
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Bergenstal RM, Nimri R, Beck RW, et al.
Lancet. 2021;397(10270):208-219.
Leggi
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Palmer SC, Tendal B, Mustafa RA, et al.
BMJ 2021;372:m4573
Leggi
Relation of first and total recurrent atherosclerotic cardiovascular disease events to increased lipoprotein(a) levels among statin treated adults with cardiovascular disease
Wong ND, Zhao Y, Sung J, Browne A
Am J Cardiol. 2021;S0002-9149(21)00031-X
Leggi
ANNALI AMD – Profili assistenziali nei soggetti con DM1 e DM2 in relazione al rischio cardiovascolare
Carissimi Soci, siamo lieti di annunciarvi la pubblicazione della nuova monografia Annali “Profili assistenziali nei soggetti con DM1 e DM2 in relazione al rischio cardiovascolare”. Le Linee Guida ESC del 2019, pubblicate in collaborazione con l'EASD, hanno riclassificato il rischio cardiovascolare nelle persone con diabete sia di Tipo 1 sia di…
Leggi
An overview of COVID‐19 in people with diabetes pathophysiology and considerations in the inpatient setting
Fleming N, Sacks LJ, Pham C, et al.
Diabet Med. 2020;e14509
Leggi
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial
Jensen J, Omar M, Kistorp C, et al.
Lancet Diabetes Endocrinol. 2020;S2213-8587(20)30382-X.
Leggi
X Convegno Nazionale Fondazione AMD
Indice congresso Le relazioni del 18 febbraio 2020 Le relazioni del 19 febbraio 2020 Le relazioni del 20 febbraio 2020 w]
Leggi
Nomenclature for kidney function and disease – executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
Levey AS, Eckardt KU, Dorman NM, et al.
Eur Heart J. 2020;41(48):4592-98
Leggi